What is it about?
Microperimetry is seeing increasing use as clinical trial endpoint for macular disease. We investigate the repeatability of a set of conventional and novel parameters derived from microperimetric tests in a range of macular conditions. Our results have implications for clinical trial design and analysis.
Featured Image
Read the Original
This page is a summary of: Intersession test—retest variability of conventional and novel parameters using the MP-1 microperimeter, Clinical Ophthalmology, December 2015, Dove Medical Press,
DOI: 10.2147/opth.s92018.
You can read the full text:
Contributors
The following have contributed to this page
